Covered recipient · General Payments record
PAMELA L BROWN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$1,307.93
- Reported across 30 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.14 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $147.69 | 2 |
| ORGANOGENESIS INC. | $50.20 | 1 |
| Corcept Therapeutics | $45.63 | 2 |
| Amgen Inc. | $41.15 | 1 |
| Acerta Pharma LLC | $33.67 | 2 |
| Exact Sciences Corporation | $14.50 | 1 |
| ABBVIE INC. | $14.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.30 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205356384 | CMS |
| Amgen Inc. | $41.15 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229090024 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.39 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206758588 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.28 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206836437 | CMS |
| Corcept Therapeutics | $16.56 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214232652 | CMS |
| Corcept Therapeutics | $29.07 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214232778 | CMS |
| Exact Sciences Corporation | $14.50 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235363399 | CMS |
| Organogenesis Inc. | $50.20 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242043614 | CMS |
| Vanda Pharmaceuticals Inc. | $124.93 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233031772 | CMS |
| Vanda Pharmaceuticals Inc. | $22.76 | 12/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233031774 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.